Trial intelligence / Profile preview

Ultrasound Guided Transversalis Fascia Plane Block for Analgesia in Cancer Surgeries

NCT07855380Recruiting

Sponsor
National Cancer Institute
Start
May 2026
Primary completion
Dec 2026
Countries
1
01

Overview

Randomised trial of bupivacaine in pain (2 arms), sponsored by National Cancer Institute. Primary endpoint: Degree of pain. Started May 2026; status: recruiting.

02

Drugs

bupivacaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT07855380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07855380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call